| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 213 | 0 | 0 | 0 | 0 | 0 | 2.834 |
| Total Expenses - EUR | 2.088 | 1.020 | 684 | 533 | 515 | 1.390 | 173 | 173 | 236 | 395 |
| Gross Profit/Loss - EUR | -2.088 | -1.020 | -684 | -321 | -515 | -1.390 | -173 | -173 | -236 | 2.438 |
| Net Profit/Loss - EUR | -2.088 | -1.020 | -684 | -321 | -515 | -1.390 | -173 | -173 | -236 | 2.438 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
Check the financial reports for the company - Endocare Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 11.937 | 11.292 | 11.032 | 10.829 | 10.619 | 10.418 | 10.187 | 10.219 | 10.188 | 0 |
| Current Assets | 1.245 | 832 | 516 | 526 | 507 | 606 | 610 | 633 | 1.063 | 957 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 413 | 440 | 455 | 480 | 498 | 600 | 555 | 565 | 569 | 342 |
| Cash | 833 | 392 | 60 | 46 | 9 | 6 | 55 | 68 | 494 | 615 |
| Shareholders Funds | -46.775 | -47.318 | -47.201 | -46.656 | -46.267 | -46.780 | -45.916 | -46.231 | -46.326 | -53.760 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 59.958 | 59.442 | 58.748 | 58.011 | 57.393 | 57.804 | 56.713 | 57.083 | 57.577 | 54.717 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Endocare Med S.r.l.